Alaunos Therapeutics (TCRT) Deferred Taxes (2009 - 2015)
Alaunos Therapeutics (TCRT) reported Deferred Taxes of -$89000.0 for Q2 2015, down 74.51% on a YoY basis from -$349153.8 in Q2 2014, and down 182.41% quarter-over-quarter from $108000.0 in Q1 2015.
Alaunos Therapeutics (TCRT) Deferred Taxes (2009 - 2015) Analysis & Trends
Alaunos Therapeutics has reported Deferred Taxes for 7 years, with the latest figure at -$89000.0 in Q2 2015.
- For the quarter ending Q2 2015, Deferred Taxes fell 74.51% year-over-year to -$89000.0; the trailing twelve-month figure through Jun 2015 stood at -$96000.0 (down 117.84% YoY), and the FY2014 full-year result was -$213000.0, down 134.08% from the prior year.
- Deferred Taxes for Q2 2015 stood at -$89000.0, down from $108000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $617000.0 in Q4 2013, with the low at -$89000.0 in Q2 2015.
- Historically, Deferred Taxes has averaged $43555.6 across 5 years, with a median of $10000.0 in 2011.
- Annual changes were most pronounced in 2013 — Deferred Taxes soared 3327.78% — and 2014, when it tumbled 1666.67%.
- Alaunos Therapeutics' Deferred Taxes stood at $97000.0 in 2011, then tumbled by 81.44% to $18000.0 in 2012, then soared by 3327.78% to $617000.0 in 2013, then plunged by 109.56% to -$59000.0 in 2014, then plunged by 50.85% to -$89000.0 in 2015.
- The last three Deferred Taxes figures came in at -$89000.0 (Q2 2015), $108000.0 (Q1 2015), and -$59000.0 (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -89,000.00 |
| Mar 31, 2015 | 108,000.00 |
| Dec 31, 2014 | -59,000.00 |
| Sep 30, 2014 | -56,000.00 |
| Jun 30, 2014 | -51,000.00 |
| Mar 31, 2014 | -47,000.00 |
| Dec 31, 2013 | 617,000.00 |
| Sep 30, 2013 | 19,000.00 |
| Jun 30, 2013 | -14,000.00 |
| Mar 31, 2013 | 3,000.00 |
| Dec 31, 2012 | 18,000.00 |
| Sep 30, 2012 | 54,000.00 |
| Jun 30, 2012 | 39,000.00 |
| Mar 31, 2012 | 133,000.00 |
| Dec 31, 2011 | 97,000.00 |
| Sep 30, 2011 | 17,000.00 |
| Jun 30, 2011 | 2,000.00 |
| Mar 31, 2011 | -7,000.00 |
| Dec 31, 2010 | -9,000.00 |
| Sep 30, 2010 | 13,000.00 |